|Bid||8.15 x 0|
|Ask||8.30 x 0|
|Day's range||8.20 - 8.34|
|52-week range||6.31 - 9.40|
|Beta (3Y Monthly)||0.22|
|PE ratio (TTM)||80.39|
|Earnings date||19 Nov. 2018 - 23 Nov. 2018|
|Forward dividend & yield||0.18 (2.16%)|
|1y target est||8.22|
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as ALS Limited (ASX:ALQ) with a market-capitalization of AU$4.4b, rarely draw their attention. However, history shows that overlooked Read More...
ALS Limited provides analytical testing services in Australia, Canada, the United States, and internationally. ALS is one of Australia’s large-cap stocks that saw some insider selling over the past threeRead More...
This article is intended for those of you who are at the beginning of your investing journey and want a simplistic look at the return on ALS Limited (ASX:ALQ) stock.Read More...
ALS Limited (ASX:ALQ) delivered a less impressive 6.01% ROE over the past year, compared to the 12.33% return generated by its industry. An investor may attribute an inferior ROE toRead More...